Vote Scores
Filings read through

Keros Therapeutics, Inc.: how funds voted at the meeting of 30 May 2024

Ticker
KROS
Meeting
Season
year to 30 June 2024
Filers reporting
254
Ballot items
4

254 filers on Form N-PX reported votes at the Keros Therapeutics, Inc. meeting of 30 May 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of Keros Therapeutics, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 70.7% of the reported votes are for. 51 filers withheld from or voted against at least one nominee.

    565 vote records from 110 filers. 37 of the 109 filers that marked the item voted against management. 1 filer gave no management mark.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 34 fund families
    • For 21
    • Abstain or withhold 13
    • Against management 13
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    389 vote records from 252 filers. 18 of the 240 filers that marked the item voted against management. 12 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 39 fund families
    • For 39
  3. Item 3: Frequency of the say-on-pay vote

    One year: 228 filers. Three years: 4 filers. For: 4 filers. : 3 filers. 1-year: 3 filers. Not applicable: 1 filer.

    364 vote records from 248 filers. 4 of the 236 filers that marked the item voted against management. 12 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 39 fund families
    • Split or no vote 39
    • Against management 1
  4. Item 4: Audit-related items (auditor ratification)

    189 vote records from 110 filers. 0 of the 109 filers that marked the item voted against management. 1 filer gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 34 fund families
    • For 34

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Keros Therapeutics, Inc., meeting of 30 May 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinForSplitNo report
American CenturyForSplitFor
BlackRock and iSharesForSplitFor
BNY MellonForSplitFor
Brighthouse FundsForSplitFor
Charles SchwabForSplitFor
Columbia ThreadneedleForSplitNo report
DimensionalForSplit, against managementFor
DWSForSplitFor
EquitableForSplitFor
FidelityForSplitFor
First TrustForSplitFor
Franklin TempletonForSplitFor
Global XForSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
InvescoForSplitFor
J.P. MorganForSplitFor
Jackson National fundsForSplitFor
Janus HendersonForSplitNo report
John Hancock and ManulifeForSplitFor
Lincoln FinancialForSplitFor
MassMutualForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitFor
NationwideForSplitFor
Neuberger BermanForSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialForSplitNo report
PrincipalForSplitFor
ProShares and ProFundsForSplitFor
Russell InvestmentsForSplitFor
SEIForSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceForSplitFor
VanguardForSplitFor
Victory CapitalForSplitFor
VoyaForSplitFor

Questions

How many filers reported votes at the Keros Therapeutics, Inc. meeting?
254 Form N-PX filers reported votes at the meeting of 30 May 2024. On say-on-pay, 18 of 240 filers that marked the item voted against management (7.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Keros Therapeutics, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Keros Therapeutics, Inc. with a meeting date within three days of 30 May 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .